Fleet Therapeutics, Inc. — Form D
Fleet Therapeutics, Inc. of BOSTON, MA, a company, filed a Form D exempt-offering notice with the SEC on 2021-10-14. The offering totals $58.1M, of which $24.1M was reported sold. Industry: Other.
Offering
- Filed: 2021-10-14
- Form: D
- Accession: 0001888097-21-000001
- Industry: Other
- Exemptions: 06b
- Total offering: $58.1M
- Amount sold: $24.1M
- Remaining: $34.0M
- Investors: 4
- Date of first sale: 2021-09-16
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-416918
Issuer
- Name: Fleet Therapeutics, Inc.
- CIK: 0001888097
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2019
- Address: 6 TIDE STREET, SUITE C, LAB C, BOSTON, MA, 02110
- Phone: 857-305-1825
Officers, directors & promoters (2)
| Name | Role | Location |
|---|
| Deborah Palestrant | Director | Berkeley, CA |
| Deborah Palestrant | Executive Officer | Berkeley, CA |
More